Amagma Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Amagma Therapeutics's estimated annual revenue is currently $2.8M per year.(i)
  • Amagma Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Amagma Therapeutics has 18 Employees.(i)
  • Amagma Therapeutics grew their employee count by 13% last year.

Amagma Therapeutics's People

NameTitleEmail/Phone
1
VP, BiologicsReveal Email/Phone
2
Senior Scientist, Protein BiochemistryReveal Email/Phone
3
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Amagma Therapeutics?

Amagma Therapeutics is a startup biotechnology company founded by proven serial entrepreneurs including Prof. Tillman Gerngross and Prof. Leonard Zon. Amagma scientists are working on the discovery and development of antibody therapeutics against inflammatory diseases (with a focus on GI disorders) which have proven intractable by other approaches. Amagma is based in Waltham, Massachusetts, and funded by private investors including Polaris Partners.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$2.8M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.6M18-5%N/A
#2
$1.6M18N/AN/A
#3
$1.4M18-65%$23.5M
#4
$3.5M18-10%$19.5M
#5
$1.8M186%$82.4M